MORE TOMORROWS

Pharmaceutical and medicinal products and preparations to treat and optimize mitochondrial function; pharmaceutical and medicinal products and preparations to treat and suppress disorders involving inherited defective mitochondria; pharmaceutical and medicinal products and preparations to treat and suppress diseases involving acquired mitochondrial dysfunction; pharmaceutical and medicinal products and preparations to treat and optimize conditions that alter energy metabolism; pharmaceutical and medicinal products and preparations to treat and suppress neurodegenerative diseases; pharmaceutical and medicinal products and preparations to treat and suppress neurological disorders; pharmaceutical and medicinal products and preparations to treat and suppress pervasive developmental disorders; pharmaceutical and medicinal products and preparations to treat and suppress cancer; pharmaceutical and medicinal products and preparations to treat and suppress ophthalmic disorders; pharmaceutical and medicinal products and preparations to treat and suppress hearing disorders